Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Détails bibliographiques
Publié dans:Philippine Star Vol. 34, no. 183 (26 Jan. 2020), 9
Auteur principal: Chante, Charles C.
Format: Article
Publié: 2020
Sujets:
Heart diseases
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Heart failure